C. S. McFarlane

1.6k total citations
20 papers, 619 citations indexed

About

C. S. McFarlane is a scholar working on Physiology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, C. S. McFarlane has authored 20 papers receiving a total of 619 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Physiology, 6 papers in Molecular Biology and 5 papers in Organic Chemistry. Recurrent topics in C. S. McFarlane's work include Asthma and respiratory diseases (10 papers), Respiratory and Cough-Related Research (3 papers) and Allergic Rhinitis and Sensitization (3 papers). C. S. McFarlane is often cited by papers focused on Asthma and respiratory diseases (10 papers), Respiratory and Cough-Related Research (3 papers) and Allergic Rhinitis and Sensitization (3 papers). C. S. McFarlane collaborates with scholars based in Canada, United States and Germany. C. S. McFarlane's co-authors include A. W. Ford‐Hutchinson, N. N. Share, Thomas R. Jones, Robert N. Young, Joshua Rokach, L. Charette, Éric Champion, P. Masson, Robert N. DeHaven and Robert Zamboni and has published in prestigious journals such as Journal of Applied Physiology, Journal of Medicinal Chemistry and Neuropharmacology.

In The Last Decade

C. S. McFarlane

19 papers receiving 579 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C. S. McFarlane Canada	14	288	199	135	100	98	20	619
P. Masson Canada	17	446 1.5×	260 1.3×	160 1.2×	214 2.1×	145 1.5×	28	860
Ralph E. Giles United States	15	370 1.3×	166 0.8×	121 0.9×	224 2.2×	47 0.5×	33	705
Katsuo Ikezawa Japan	15	227 0.8×	249 1.3×	61 0.5×	101 1.0×	72 0.7×	47	585
Winston S. Marshall United States	10	213 0.7×	220 1.1×	82 0.6×	65 0.7×	113 1.2×	20	564
T. Hesselbo United Kingdom	5	102 0.4×	180 0.9×	79 0.6×	62 0.6×	35 0.4×	9	584
Jan‐Anders Karlsson Sweden	10	197 0.7×	314 1.6×	81 0.6×	91 0.9×	61 0.6×	15	492
Victoria Boswell‐Smith United Kingdom	8	247 0.9×	383 1.9×	138 1.0×	166 1.7×	76 0.8×	8	709
J.R. Boot United Kingdom	11	155 0.5×	159 0.8×	247 1.8×	50 0.5×	54 0.6×	21	523
Mary G. Huber United States	7	125 0.4×	137 0.7×	107 0.8×	52 0.5×	26 0.3×	9	393
Stephen L. Underwood United Kingdom	12	292 1.0×	171 0.9×	41 0.3×	222 2.2×	20 0.2×	16	588

Countries citing papers authored by C. S. McFarlane

Since Specialization

Citations

This map shows the geographic impact of C. S. McFarlane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. S. McFarlane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. S. McFarlane more than expected).

Fields of papers citing papers by C. S. McFarlane

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. S. McFarlane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. S. McFarlane. The network helps show where C. S. McFarlane may publish in the future.

Co-authorship network of co-authors of C. S. McFarlane

This figure shows the co-authorship network connecting the top 25 collaborators of C. S. McFarlane. A scholar is included among the top collaborators of C. S. McFarlane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. S. McFarlane. C. S. McFarlane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Guay, Daniel, J. Y. GAUTHIER, C. DUFRESNE, et al.. (1998). A series of non-quinoline cysLT1 receptor antagonists: Sar study on pyridyl analogs of singulair®. Bioorganic & Medicinal Chemistry Letters. 8(5). 453–458. 7 indexed citations

Jones, Thomas R., M. McAuliffe, C. S. McFarlane, et al.. (1998). Effects of a selective phosphodiesterase IV inhibitor (CDP-840) in a leukotriene-dependent non-human primate model of allergic asthma. Canadian Journal of Physiology and Pharmacology. 76(2). 210–217. 18 indexed citations

Jones, Tom R., M. McAuliffe, C. S. McFarlane, et al.. (1998). Effects of a selective phosphodiesterase IV inhibitor (CDP-840) in a leukotriene-dependent non-human primate model of allergic asthma.. PubMed. 76(2). 210–7. 20 indexed citations

Hutchinson, John H., S. Charleson, Jilly F. Evans, et al.. (1996). ChemInform Abstract: Thiopyranol(2,3,4‐c,d)indoles as Inhibitors of 5‐Lipoxygenase, 5‐ Lipoxygenase‐Activating Protein, and Leukotriene C4 Synthase.. ChemInform. 27(10). 4 indexed citations

Hutchinson, John H., S. Charleson, Jillian F. Evans, et al.. (1995). Thiopyranol[2,3,4-c,d]indoles as Inhibitors of 5-Lipoxygenase, 5-Lipoxygenase-Activating Protein, and Leukotriene C4 Synthase. Journal of Medicinal Chemistry. 38(22). 4538–4547. 34 indexed citations

Lau, Cheuk K., C. DUFRESNE, Yves Gareau, et al.. (1995). Evolution of a series of non-quinoline leukotriene D4 receptor antagonist; synthesis and sar of benzothiazoles and thiazoles substituted benzyl alcohols as potent LTD4 antagonists. Bioorganic & Medicinal Chemistry Letters. 5(15). 1615–1620. 27 indexed citations

Ducharme, Yves, Christine Brideau, Daniel Dubé, et al.. (1994). Naphthalenic Lignan Lactones as Selective, Nonredox 5-Lipoxygenase Inhibitors. Synthesis and Biological Activity of (Methoxyalkyl)thiazole and Methoxytetrahydropyran Hybrids. Journal of Medicinal Chemistry. 37(4). 512–518. 31 indexed citations

Hutchinson, John H., Denis Riendeau, Christine Brideau, et al.. (1994). ChemInform Abstract: Substituted Thiopyrano(2,3,4‐c,d)indoles as Potent, Selective, and Orally Active Inhibitors of 5‐Lipoxygenase. Synthesis and Biological Evaluation of L‐691,816.. ChemInform. 25(10).

Jones, Thomas R., Robert Zamboni, Michel Belley, et al.. (1991). Pharmacology of the leukotriene antagonist verlukast: The (R)-enantiomer of MK-571. Canadian Journal of Physiology and Pharmacology. 69(12). 1847–1854. 17 indexed citations

10.

Prasit, Petpiboon, Michel Belley, Jilly F. Evans, et al.. (1991). A new class of leukotriene biosynthesis inhibitors: The development of ((4-(4-chlorophenyl)-1-(4-(2-quinolinylmethoxy)phenyl)butyl)thio)acetic acid, L-674,636. Bioorganic & Medicinal Chemistry Letters. 1(11). 645–648. 8 indexed citations

11.

Jones, Thomas R., Robert Zamboni, Michel Belley, et al.. (1989). Pharmacology of L-660,711 (MK-571): a novel potent and selective leukotriene D₄ receptor antagonist. Canadian Journal of Physiology and Pharmacology. 67(1). 17–28. 232 indexed citations

12.

McFarlane, C. S., R. Hamel, & A. W. Ford‐Hutchinson. (1987). Effects of a 5-lipoxygenase inhibitior (L-651,392) on primary and late pulmonary responses to ascaris antigen in the squirrel monkey. Inflammation Research. 22(1-2). 63–68. 18 indexed citations

13.

McFarlane, C. S., et al.. (1987). Effects of a 5-lipoxygenase inhibitor (L-651,392) and leukotriene D4 antagonist (L-649,923) in two animal models of immediate hypersensitivity reactions.. PubMed. 17B. 1007–11. 3 indexed citations

14.

Hamel, R., C. S. McFarlane, & A. W. Ford‐Hutchinson. (1986). Late pulmonary responses induced by Ascaris allergen in conscious squirrel monkeys. Journal of Applied Physiology. 61(6). 2081–2087. 32 indexed citations

15.

Jones, Thomas R., Robert N. Young, Éric Champion, et al.. (1986). L-649,923, Sodium (βS*, γR*)-4-(3-(4-acetyl-3-hydroxy-2-propylphenoxy)-propylthio)-γ-hydroxy-β-methylbenzenebutanoate, a selective, orally active leukotriene receptor antagonist. Canadian Journal of Physiology and Pharmacology. 64(8). 1068–1075. 51 indexed citations

16.

Jones, Thomas R., Yvan Guindon, Robert N. Young, et al.. (1986). L-648,051, sodium 4-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)-propylsulfonyl]-γ-oxo-benzenebutanoate: a leukotriene D₄ receptor antagonist. Canadian Journal of Physiology and Pharmacology. 64(12). 1535–1542. 28 indexed citations

17.

McFarlane, C. S., H. Piechuta, R. A. Hall, & A. W. Ford‐Hutchinson. (1984). Effects of a contractile prostaglandin antagonist (L-640, 035) upon allergen-induced bronchoconstriction in hyperreactive rats and conscious squirrel monkeys. Prostaglandins. 28(2). 173–182. 13 indexed citations

18.

ATKINSON, J. G., Yves Girard, Joshua Rokach, et al.. (1979). Kojic amine - a novel .gamma.-aminobutyric acid analog. Journal of Medicinal Chemistry. 22(1). 99–106. 27 indexed citations

19.

Share, N. N. & C. S. McFarlane. (1975). Cyclobenzaprine: A novel centrally acting skeletal muscle relaxant. Neuropharmacology. 14(9). 675–684. 48 indexed citations

20.

McFarlane, C. S., et al.. (1964). A New Central Sympatholytique: 2 [<i>β</i>- (N-morpholino)- ethylaminomethyl]-1, 4-benzodioxan dihydrochloride. Chemotherapy. 9(4-5). 259–261. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact